Modified 2'-ribose small RNAs function as Toll-like receptor-7/8 antagonists.

Area of Science:

• Immunology
• Molecular Biology
• RNA Therapeutics

Background:

• Toll-like receptors (TLRs) recognize nucleic acids, including self-RNAs, potentially causing inflammatory diseases.
• Modifying RNA nucleotides can prevent unwanted immune stimulation.
• 2'-O-methyl RNA modifications evade immune activation and suppress TLR signaling.

Purpose of the Study:

• To characterize synthetic small RNAs as potential Toll-like receptor (TLR) antagonists.
• To investigate the ability of RNA modifications to suppress TLR signaling.

Main Methods:

• Synthesis of short small RNAs with specific modifications, including 2'-O-methyl.
• In vitro characterization of RNA's ability to suppress immunostimulatory activity in-trans.

Main Results:

• Small RNAs with 2'-ribose modifications, specifically 2'-O-methyl, suppressed TLR signaling.
• These modified RNAs acted as antagonists to immunostimulatory RNAs.

Conclusions:

• Synthetic small RNAs with 2'-O-methyl modifications are effective TLR antagonists.
• These findings suggest potential therapeutic applications for inflammatory conditions mediated by TLRs.
• Endogenous RNA modifications may also play a role in regulating TLR responses.